Free Trial

REGENXBIO (RGNX) SEC Filings & 10K Form

REGENXBIO logo
$7.37 +0.22 (+3.08%)
As of 01/17/2025 04:00 PM Eastern

Recent REGENXBIO SEC Filings

DateFilerForm TypeView
01/14/2025
4:19 PM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4/A
01/14/2025
6:08 AM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2025
5:45 PM
BlackRock, Inc. (Filed by)
REGENXBIO (Subject)
Form SCHEDULE 13G
12/30/2024
3:09 PM
REGENXBIO (Subject)
Vasista Vittal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
12/09/2024
4:12 PM
REGENXBIO (Filer)
Form 424B5
12/09/2024
3:45 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/14/2024
8:00 PM
Redmile Group, LLC (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
11/06/2024
3:10 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/04/2024
12:49 PM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
10/17/2024
10:42 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
09/18/2024
4:03 PM
Chan Mitchell (Reporting)
REGENXBIO (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/18/2024
4:04 PM
Chan Mitchell (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2024
4:00 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/04/2024
7:20 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:58 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:38 PM
Danos Olivier (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:39 PM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:39 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:39 PM
Christmas Patrick J. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
5:41 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
3:34 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/01/2024
3:20 PM
REGENXBIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/30/2024
4:01 PM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
4:01 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/29/2024
3:13 PM
REGENXBIO (Subject)
Simpson Curran (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/26/2024
4:00 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/18/2024
4:05 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
6:55 AM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2024
6:56 AM
REGENXBIO (Issuer)
Simpson Curran (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2024
3:42 PM
KARABELAS ARGERIS N (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
06/12/2024
7:46 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
3:43 PM
MIGAUSKY GEORGE V (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:43 PM
REGENXBIO (Issuer)
Zachary Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:39 PM
REGENXBIO (Issuer)
STUMP DAVID C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:40 PM
REGENXBIO (Issuer)
Tasse Daniel (Reporting)
Tasse Daniel (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:41 PM
Fox Allan M. (Reporting)
REGENXBIO (Issuer)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:35 PM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/16/2024
4:06 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:22 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/08/2024
3:16 PM
REGENXBIO (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/17/2024
4:05 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
WARNING: “Buffett Indicator” flashing for first time in 50 years (Ad)

Warren Buffett has sold a staggering $97 billion worth of stocks this year... But why? Our research indicates the Oracle of Omaha is quietly preparing for a historic market crash. His most reliable crash indicator - the "Buffett indicator" - just flashed red for the first time in 25 years.

Take these 4 steps today to protect your retirement NOW
04/04/2024
3:11 PM
REGENXBIO (Filer)
Form DEF 14A
04/04/2024
3:15 PM
REGENXBIO (Filer)
Form DEFA14A
04/04/2024
3:20 PM
REGENXBIO (Filer)
Form ARS
03/21/2024
4:20 PM
REGENXBIO (Issuer)
Vasista Vittal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2024
7:00 AM
REGENXBIO (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/08/2024
5:09 AM
REGENXBIO (Filer)
Form 424B5
03/07/2024
5:05 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/07/2024
5:03 AM
REGENXBIO (Subject)
Form FWP
03/06/2024
3:23 PM
REGENXBIO (Filer)
Form 424B5
03/05/2024
3:26 PM
PAKOLA STEVE (Reporting)
REGENXBIO (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/16/2024
5:28 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2024
4:13 PM
REGENXBIO (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/05/2024
2:04 PM
GIC Private Ltd (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
10:10 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
10:11 AM
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/25/2024
6:16 AM
REGENXBIO (Subject)
STATE STREET CORP (Filed by)
Form SC 13G/A
01/19/2024
1:40 PM
BlackRock Inc. (Filed by)
REGENXBIO (Subject)
Form SC 13G/A
01/18/2024
5:39 PM
Mills Kenneth T. (Reporting)
REGENXBIO (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:RGNX) was last updated on 1/19/2025 by MarketBeat.com Staff
From Our Partners